CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus

Journal of Clinical Investigation

Volumn 106, Issue 1, 2000, Pages 91-101

  Mihara, Masahiko ^a,c   Tan, Irene ^a   Chuzhin, Yelena ^a   Reddy, Bhoompally ^a   Budhai, Lalbachan ^a   Holzer, Aton ^a   Gu, Gun ^b   Davidson, Anne ^a,b  

^a Department of Medicine ^*  (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 0033932756     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI9244     Document Type: Article

References (42)

1. Raz, E., Brevis, M., Rosenmann, E., and Eilat, D. 1989. Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J. Immunol. 142:3076-3082.
2. Diamond, B., et al. 1992. The role of somatic mutation in pathogenic anti-DNA annbodies. Annu. Rev. Immunol. 10:731-757.
3. Reiser, H., and Stadecker, M.J. 1996. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N. Engl. J. Med. 335:1369-1377.
4. Lederman, S., et al. 1996. T lymphocyte mediated differentiation of B lymphocytes the central role of the CD40-ligand:CD40 pathway. Curr. Opin. Hematol. 3:77-86.
5. Wofsy, D., and Daikh, D.I. 1998. Opportunities for future biological therapy in SLE. Baillieres Clin. Rheumatol. 12:529-541.
6. Grewal, I.S., and Flavell, R.A. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111-135.
7. Lindhout, E., Koopman, G., Pals, S.T., and de Groot, C. 1997. Triple check for antigen specificity of B cells during germinal centre reactions. Immunol. Today. 18:573-577.
8. Tarlinton, D. 1998. Germinal centers: form and function. Curr. Opin. Immunol. 10:245-251.
9. Mamula, M.J. 1998. Epitope spreading: the role of self peptides and autoantigen processing by B lymphocytes. Immunol. Rev. 164:231-239.
10. Chan, O., and Shlomchik, M.J. 1998. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. J. Immunol. 160:51-59.
11. Sayegh, M.H. 1999. Finally, CTLA4Ig graduates to the clinic J. Clin. Invest. 103:1223-1225.
12. Linsley, P.S., et al. 1994. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity. 1:793-801.
13. Abrams, J.R., et al. 1999. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J. Clin. Invest. 103:1243-1252.
14. Guinan, E.C., et al. 1999. Transplantation of anergic histoincompatible bone marrow allografts. N. Engl. J. Med. 340:1704-1714.
15. Finck, B.K., Linsley, P.S., and Wofsy, D. 1994. Treatment of murine lupus with CTLA4Ig. Science. 265:1225-1227.
16. Ilan, Y., et al. 1998. Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenoviruses. Hepatology. 27:1368-1376.
17. Ray, S., and Diamond, B. 1994. Generation of a fusion partner to sample the repertoire of splenic B cells destined for apoptosis. Proc. Natl. Acad. Sci. USA. 91:5558-5551.
18. Nieto, A., Gaya, A., Jansa, M., Moreno, C., and Vines, J. 1984. Direct measurement of antibody affinity distribution by hapten-inhibition enzyme immunoassay. Mol. Immunol. 21:537-543
19. Kuo, P., Alban, A., Gebhard, D., and Diamond, B. 1997. Overexpression of bcl-2 alters usage of mutational hot spots in germinal center B cells. Mol. Immunol. 34:1011-1018.
20. Li, S.C., et al. 1994. Expression of 1μ-Cγhybrid germline transcripts subsequent to immunoglobulin heavy chain class switching. Int. Immunol. 6:491-497.
21. H gene in immunized and autoimmune mice. J. Immunol. 159:1508-1519.
22. H gene sequences. J. Clin. Invest. 91:402-408.
23. Zylstra, P., Rothenfluh, H.S., Weiller, G.F., Blanden, R.V., and Steele, E.J. 1998. PCR amplification of murine immunoglobulin germline V genes: strategies for minimization of recombination artefacts. Immunol. Cell. Biol. 76:395-405.
24. Neuberger, M.S., et al. 1998. Monitoring and interpreting the intrinsic features of somatic mutation. Immunol. Rev. 162:107-116.
25. Bradley, L.M., Croft, M., and Swain, S.L. 1993. T cell memory: new perspectives. Immunol. Today. 14:197-199.
26. Budhai, L., Oh, K., and Davidson, A. 1996. An in vitro assay for detection of glomerular binding IgG autoantibodies in patients with SLE. J. Clin. Invest. 98:1585-1593.
27. Krishnan, M.R., Jou, N.T., and Marion, T.N. 1996. Correlation between the amino acid position of arginine in VH-CDR3 and specificity for native DNA among autoimmune antibodies. J. Immunol. 157:2430-2439.
28. Theofilopoulos, A.N., and Dixon, F.J. 1985. Murine models of systemic lupus erythematosus. Adv Immunol. 37:269-390.
29. 1 murine SLE model. J. Immunol. 138:3185-3190.
30. 1 hybrid mice. J. Immunol. 138:2890-2895.
31. 1 mice: analysis of T-cell lymphokine synthesis. Immunology. 85:26-32.
32. Datta, S.K., Patel, H., and Berry, D. 1987. Induction of a cationic shift in IgG anti-DNA autoantibodies. J. Exp. Med. 165:1252-1268.
33. 1 mice. J. Exp. Med. 184:853-861.
34. Mihara, M., et al. 1988. Immunologic abnormality in NZB/NZW F1 mice. Thymus-independent occurrence of B cell abnormality and requirement for T cells in the development of autoimmune disease, as evidenced by an analysis of the athymic nude individuals. J. Immunol. 141:85-90.
35. Lane, P., et al. 1994. B cell function in mice transgenic for mCTLA4-H gamma 1 : lack of germinal centers correlated with poor affinity maturation and class switching despite normal priming of CD4+ T cells. J. Exp. Med. 179:819-830.
36. Green, J.M., et al. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity. 1:501-508.
37. Slifka, M.K., Antia, R., Whitmire, J.K., and Ahmed, R. 1998. Humoral immunity due to long-lived plasma cells. Immunity 8:363-372.
38. Manz, R.A., Lohning, M., Cassese, G., Thiel, A., and Radbruch, A. 1998. Survival of long-lived plasma cells is independent of antigen. Int. Immunol. 10:1703-1711.
39. Zimmermann, C., Seiler, P., Lane, P., and Zinkernagel, R.M. 1997. Antiviral immune responses in CTLA4 transgenic mice. J. Virol. 71:1802-1807.
40. Schaub, M., Stadlbauer, T.H.W., and Sayegh, M.H. 1997. CTLA4Ig: effects on cellular and humoral immunity and macrophage activation. Exp. Nephrol. 5:370-374.
41. Daikh, D.I., Finck, B.K., Linsley, P.S., Hollenbaugh, D., and Wofsy, D. 1997. Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways. J Immunol. 159:3104-3108.
42. Cunnane, G., et al. 1999. Effects of combined CTLA4Ig and cyclophosphamide on renal pathology in advanced murine lupus. Arthritis Rheum. 42:S359. (Absrt.)